UBS Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,557
Closed -$25.4K 9252
2024
Q3
$25.4K Buy
+6,557
New +$25.4K ﹤0.01% 6027
2024
Q2
Sell
-3,733
Closed -$10.5K 8932
2024
Q1
$10.5K Buy
3,733
+3,659
+4,945% +$10.3K ﹤0.01% 6053
2023
Q4
$235 Buy
+74
New +$235 ﹤0.01% 7571
2023
Q1
Sell
-2,033
Closed -$7.34K 9249
2022
Q4
$7.34K Buy
2,033
+1,291
+174% +$4.66K ﹤0.01% 7713
2022
Q3
$6K Sell
742
-1,194
-62% -$9.66K ﹤0.01% 7987
2022
Q2
$15K Sell
1,936
-186
-9% -$1.44K ﹤0.01% 6286
2022
Q1
$20K Sell
2,122
-3,472
-62% -$32.7K ﹤0.01% 6422
2021
Q4
$39K Buy
5,594
+5,121
+1,083% +$35.7K ﹤0.01% 6056
2021
Q3
$4K Buy
473
+362
+326% +$3.06K ﹤0.01% 7551
2021
Q2
$1K Sell
111
-1,226
-92% -$11K ﹤0.01% 8094
2021
Q1
$15K Buy
1,337
+395
+42% +$4.43K ﹤0.01% 6611
2020
Q4
$34K Sell
942
-662
-41% -$23.9K ﹤0.01% 5537
2020
Q3
$23K Buy
1,604
+1,493
+1,345% +$21.4K ﹤0.01% 5354
2020
Q2
$2K Sell
111
-1,165
-91% -$21K ﹤0.01% 6809
2020
Q1
$11K Buy
1,276
+673
+112% +$5.8K ﹤0.01% 5976
2019
Q4
$14K Sell
603
-304
-34% -$7.06K ﹤0.01% 6035
2019
Q3
$13K Buy
907
+271
+43% +$3.88K ﹤0.01% 6046
2019
Q2
$8K Sell
636
-157
-20% -$1.98K ﹤0.01% 6332
2019
Q1
$14K Sell
793
-1,248
-61% -$22K ﹤0.01% 5769
2018
Q4
$28K Buy
2,041
+1,550
+316% +$21.3K ﹤0.01% 5630
2018
Q3
$11K Sell
491
-524
-52% -$11.7K ﹤0.01% 6206
2018
Q2
$44K Buy
1,015
+372
+58% +$16.1K ﹤0.01% 5183
2018
Q1
$42K Buy
643
+189
+42% +$12.3K ﹤0.01% 5002
2017
Q4
$33K Buy
454
+95
+26% +$6.91K ﹤0.01% 5208
2017
Q3
$33K Sell
359
-65
-15% -$5.98K ﹤0.01% 5204
2017
Q2
$28K Buy
424
+202
+91% +$13.3K ﹤0.01% 5132
2017
Q1
$48K Sell
222
-628
-74% -$136K ﹤0.01% 4655
2016
Q4
$79K Sell
850
-115
-12% -$10.7K ﹤0.01% 4570
2016
Q3
$131K Sell
965
-205
-18% -$27.8K ﹤0.01% 3999
2016
Q2
$119K Buy
1,170
+512
+78% +$52.1K ﹤0.01% 4091
2016
Q1
$107K Sell
658
-7,782
-92% -$1.27M ﹤0.01% 4187
2015
Q4
$2.76M Buy
8,440
+6,474
+329% +$2.12M ﹤0.01% 1952
2015
Q3
$634K Buy
1,966
+575
+41% +$185K ﹤0.01% 2939
2015
Q2
$554K Buy
1,391
+235
+20% +$93.6K ﹤0.01% 3195
2015
Q1
$569K Buy
1,156
+406
+54% +$200K ﹤0.01% 3144
2014
Q4
$268K Buy
+750
New +$268K ﹤0.01% 3581